- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Mar 19, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
516 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARDX | US$8.02 | -4.8% | 93.7% | US$1.9b | US$13.31 | PS15x | E60.6% | n/a | ||
A214370 | ₩22,850.00 | -9.7% | -43.9% | ₩1.1t | ₩50,000.00 | PE28.1x | E42.7% | 2.8% | ||
603392 | CN¥73.21 | 0.3% | -15.6% | CN¥92.8b | CN¥69.43 | PE35.7x | E34.3% | 1.0% | ||
EGTX | kr6.49 | 3.8% | 29.0% | kr1.9b | kr13.13 | PS33x | E87.5% | n/a | ||
BINV | kr16.40 | -3.2% | -39.1% | kr1.1b | kr108.50 | PS15.1x | E60.1% | n/a | ||
BIOA B | kr224.80 | -3.2% | -6.1% | kr19.9b | kr366.20 | PE86.6x | E48.2% | 0% | ||
FOLD | US$11.84 | 0.4% | 4.7% | US$3.5b | US$19.00 | PS8.8x | E53.3% | n/a | ||
MIRM | US$27.01 | -1.7% | 17.0% | US$1.3b | US$49.00 | PS6.8x | E63.2% | n/a | ||
688278 | CN¥66.57 | 4.2% | 53.7% | CN¥27.1b | n/a | PE48.9x | E29.0% | 0.3% | ||
603229 | CN¥11.25 | 2.3% | -34.5% | CN¥6.7b | n/a | PE23.5x | E27.3% | 0.7% | ||
BIOVIC B | kr2.30 | -2.5% | -72.6% | kr193.3m | kr15.00 | PS27.8x | E83.0% | n/a | ||
STX | UK£0.021 | -8.6% | -64.3% | UK£16.6m | n/a | PS2.9x | E86.9% | n/a | ||
AVDL | US$15.80 | -1.1% | 96.8% | US$1.4b | US$22.90 | PS51.2x | E56.7% | n/a | ||
NWRN | CHF7.86 | -2.0% | 35.1% | CHF140.6m | CHF11.56 | PS16.6x | E51.0% | n/a | ||
APLS | US$56.92 | -2.7% | -8.3% | US$6.9b | US$82.69 | PS17.3x | E60.1% | n/a | ||
4147 | NT$89.40 | -1.7% | 12.5% | NT$22.6b | NT$129.02 | PS34.3x | E109.1% | n/a | ||
A206650 | ₩12,130.00 | -4.5% | 65.5% | ₩442.2b | ₩15,000.00 | PS7.4x | E77.6% | n/a | ||
688621 | CN¥62.08 | 9.5% | -24.1% | CN¥7.0b | n/a | PE35.8x | E37.2% | 0.7% | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
AGRX | US$0.53 | -27.6% | -95.6% | US$1.6m | n/a | PE-0.1x | E56.9% | n/a | ||
ENSC | US$0.83 | 13.2% | -87.4% | US$6.1m | US$13.60 | PS2.7x | E62.6% | n/a | ||
SPRY | US$8.46 | 0% | 0% | US$812.1m | US$18.50 | PS27071.2x | E51.3% | n/a | ||
MGTX | US$6.28 | 3.5% | 14.2% | US$403.3m | US$21.60 | PS28.8x | E52.8% | n/a |